War can transform pharmaceutical logistics from a routine transportation function into a critical healthcare-continuity challenge.
Pharmaceutical products depend on predictable movement across manufacturers, warehouses, ports, airports, customs systems, distributors, and healthcare facilities. During armed conflict, any of these links can become disrupted.
The risks are not limited to physical damage.
War can also affect:
- Shipping routes
- Airspace
- Ports and airports
- Fuel availability
- Freight capacity
- Warehousing
- Cold-chain operations
- Customs clearance
- Insurance
- Workforce availability
- Pharmaceutical raw materials
- Delivery schedules
The World Health Organization (WHO) reports that the current Middle East conflict has disrupted airspace and maritime routes, affecting the movement of humanitarian supplies and medical equipment beyond the immediate region.
Recent experience in Ukraine also demonstrates how attacks on warehouses containing medical supplies can directly disrupt pharmaceutical logistics. WHO reported in September 2026 that three warehouses used for humanitarian medical supplies had been destroyed in three months.
For pharmaceutical manufacturers and exporters, the central issue is therefore not simply transportation cost.
It is how to maintain safe, compliant, and reliable medicine movement when normal logistics routes become uncertain.
Why Pharmaceutical Logistics Is Vulnerable During War
Pharmaceutical logistics is more complex than moving products from one location to another.
A typical international pharmaceutical shipment may involve:
Manufacturer → Warehouse → Freight Provider → Port/Airport → Customs → Importer → Distributor → Pharmacy/Hospital
Each stage can introduce a potential point of disruption.
During conflict, companies may face:
- Route closures
- Security restrictions
- Port congestion
- Airspace closures
- Fuel shortages
- Border delays
- Damaged infrastructure
- Warehouse relocation
- Workforce shortages
- Higher insurance costs
- Longer transit times
WHO guidance on health logistics also identifies transportation limitations, longer journeys, supply disruptions, and cold-chain risks as important challenges during emergencies and disasters.
Top Pharmaceutical Logistics Risks During War
Several risks become particularly important when pharmaceutical supply chains operate in conflict-affected or conflict-adjacent regions.
1. Shipping Route Disruptions
Maritime transportation is a major component of international pharmaceutical logistics.
Conflict can make certain shipping corridors less accessible or less predictable.
Companies may need to reroute vessels or use alternative ports.
This can result in:
- Longer transit times
- Higher freight costs
- Additional handling
- Port congestion
- Schedule uncertainty
- Increased inventory requirements
For pharmaceutical exporters, a shipping route should therefore be evaluated not only for cost but also for reliability and contingency options.
2. Airspace Restrictions
Air freight is important for time-sensitive pharmaceutical products.
It is commonly used when shipments require faster transportation than conventional sea freight.
During conflict, airspace restrictions can affect:
- Flight availability
- Cargo capacity
- Transit routes
- Airport operations
- Emergency deliveries
- Pharmaceutical shipment schedules
WHO reported in March 2026 that temporary airspace restrictions in the Middle East disrupted the movement of medical supplies from its global logistics hub in Dubai, creating significant shipment backlogs.
This illustrates how an airspace disruption in one region can affect medical supply movement beyond that region.
3. Port Closures and Congestion
Ports are critical pharmaceutical logistics nodes.
When a port is:
- Closed
- Damaged
- Overloaded
- Restricted
- Operating at reduced capacity
pharmaceutical shipments may be delayed.
A shipment may then require:
Original Port → Alternative Port → Additional Inland Transport
This creates additional planning requirements.
For exporters, alternative-port planning should ideally be established before a disruption occurs.
4. Fuel Shortages
Fuel availability is essential to pharmaceutical logistics.
Fuel is required for:
- Trucks
- Delivery vehicles
- Ships
- Aircraft
- Warehouses
- Generators
- Refrigerated transportation
During conflict, fuel supply can become constrained.
This can affect not only transportation but also the operation of healthcare facilities and cold-chain systems.
A June 2026 UN briefing noted that refined-fuel shortages were affecting generators, cold chains, ambulances, humanitarian logistics, and pharmaceutical supply chains, including transportation costs and the movement of pharmaceutical intermediates and active ingredients.
5. Cold-Chain Disruption
Cold-chain logistics is one of the most sensitive areas of pharmaceutical transportation.
Temperature-sensitive products may require:
- Controlled transportation
- Validated packaging
- Temperature monitoring
- Refrigerated storage
- Qualified logistics providers
- Reliable electricity
War can increase the risk of:
- Power interruptions
- Refrigeration failures
- Longer transit times
- Delayed customs clearance
- Unplanned storage
- Temperature excursions
WHO guidance notes that longer and more complex transport journeys can increase the risk of cold-chain problems and temperature excursions.
For temperature-sensitive medicines, logistics contingency planning must therefore include both route continuity and temperature-control continuity.
6. Warehouse Damage or Relocation
Pharmaceutical warehouses are important strategic points in global supply chains.
During conflict, warehouses can be exposed to:
- Physical damage
- Evacuation requirements
- Power disruption
- Security restrictions
- Access limitations
- Inventory loss
WHO reported that attacks on medical-supply warehouses in Ukraine have disrupted the availability of essential supplies and forced health organizations to move inventory to alternative storage locations.
A resilient pharmaceutical logistics strategy should therefore consider:
- Secondary warehouses
- Geographic diversification
- Emergency inventory transfer
- Backup power
- Stock visibility
- Alternative storage arrangements
7. Customs and Border Delays
International pharmaceutical shipments require customs and regulatory processing.
During conflict, border procedures may become slower or less predictable.
Potential problems include:
- Border closures
- Reduced customs capacity
- Additional inspections
- Documentation delays
- Security restrictions
- Changes in import procedures
For pharmaceutical exporters, documentation accuracy becomes even more important when operating under disrupted conditions.
Errors that might normally be corrected quickly can create longer delays when customs and logistics systems are under pressure.
8. Freight Capacity Shortages
War can change the availability of transportation capacity.
Companies may compete for limited:
- Container capacity
- Air-cargo space
- Trucks
- Warehousing
- Specialized pharmaceutical logistics services
This can increase freight costs and make emergency shipments more difficult.
For exporters, maintaining relationships with multiple logistics providers can provide additional flexibility.
9. Higher Insurance and Security Costs
Conflict can increase perceived transportation risk.
This may influence:
- Cargo insurance
- War-risk insurance
- Security arrangements
- Freight premiums
- Route selection
Higher insurance costs can increase the overall landed cost of pharmaceutical products.
However, the exact impact varies by route, destination, cargo type, insurer, and prevailing risk conditions.
10. Longer Pharmaceutical Lead Times
One of the most common consequences of logistics disruption is longer lead time.
A shipment that normally takes a predictable period may require additional time because of:
Route Changes + Port Delays + Customs Delays + Security Restrictions + Transshipment
Longer lead times can affect:
- Inventory planning
- Customer commitments
- Hospital supply
- Distributor stock
- Production schedules
- Working capital
This makes accurate lead-time forecasting increasingly important during geopolitical instability.
11. Pharmaceutical Raw Material Transportation Risks
Finished medicines are only one part of the pharmaceutical supply chain.
Manufacturers also depend on the movement of:
- APIs
- Excipients
- Solvents
- Chemical intermediates
- Packaging materials
- Laboratory supplies
A transportation disruption affecting any of these inputs can eventually affect finished-product production.
WHO guidance has highlighted how supply-chain disruptions can affect APIs, consumables, shipping, procurement, finished healthcare products, and raw materials.
12. Inventory Shortage and Stockout Risk
When transportation becomes unpredictable, companies may experience inventory pressure.
The sequence can look like:
Longer Lead Time → Delayed Replenishment → Lower Inventory → Higher Stockout Risk
Essential medicines can be particularly sensitive because demand may continue even when transportation conditions deteriorate.
Companies may therefore need to reassess safety-stock levels according to:
- Product criticality
- Demand
- Supplier reliability
- Lead time
- Route risk
- Market requirements
13. Documentation and Regulatory Risk
Emergency logistics changes can create regulatory complications.
A company may need to change:
- Shipping routes
- Freight providers
- Warehouses
- Importers
- Packaging arrangements
- Distribution partners
Some changes may have regulatory implications depending on the market and product.
Therefore, logistics teams should coordinate closely with:
- Regulatory teams
- Quality teams
- Compliance teams
- Import partners
A faster shipment is not useful if it creates a regulatory or quality problem.
14. Shipment Visibility Problems
During stable conditions, pharmaceutical companies can often track shipments through standard logistics systems.
During conflict, visibility may become less reliable.
Potential problems include:
- Delayed tracking updates
- Communication outages
- Route changes
- Unplanned transshipment
- Limited carrier information
Digital shipment visibility becomes particularly important when products are moving through multiple alternative routes.
15. Security Risks for Pharmaceutical Transport
Pharmaceutical logistics can also face physical security challenges.
Companies may need to consider:
- Route security
- Driver safety
- Cargo protection
- Warehouse access
- Checkpoints
- Movement restrictions
Medical transport itself can become vulnerable during conflict.
WHO reported in May 2026 that approximately 20% of verified attacks on healthcare in Ukraine involved ambulances and other health vehicles, highlighting the wider vulnerability of medical transport systems during war.
How War Can Affect Indian Pharmaceutical Logistics
India is a major pharmaceutical manufacturing and exporting base.
Indian pharmaceutical exporters can be affected by war-related logistics disruption even when manufacturing facilities are located outside the conflict zone.
The impact can occur through:
- International shipping routes
- Air freight
- Fuel prices
- Port operations
- Insurance
- Destination-market disruptions
- Raw-material transportation
- Distributor operations
For Indian exporters, supply-chain resilience therefore requires visibility beyond the factory gate.
Indian Pharma Exporters and Alternative Logistics Routes
A resilient export strategy can include multiple transportation options.
Depending on the product and market, companies may evaluate:
- Alternative seaports
- Alternative airports
- Different shipping corridors
- Multiple freight providers
- Sea-air combinations
- Regional inventory locations
Not every alternative will be suitable for every pharmaceutical product.
Product quality, regulatory requirements, cost, transit time, and storage conditions must all be considered.
Cold-Chain Planning for Indian Pharma Exports
Indian pharmaceutical exporters handling temperature-sensitive products need additional contingency planning.
Important considerations include:
Validated Packaging
Packaging should be appropriate for the required temperature range and transportation duration.
Temperature Monitoring
Shipments should use suitable monitoring systems where required.
Backup Storage
Alternative temperature-controlled storage can reduce exposure during unexpected delays.
Route Planning
Routes should account for potential delays at ports, airports, and borders.
Emergency Response
Teams should have defined procedures for shipment delays and temperature excursions.
Pharmaceutical Logistics Risk Management Framework
A structured risk-management framework can help exporters prepare for disruption.
Step 1: Map the Supply Chain
Identify:
- Suppliers
- Manufacturing sites
- Warehouses
- Ports
- Airports
- Freight providers
- Distributors
Step 2: Identify Critical Dependencies
Determine which routes, suppliers, and facilities are difficult to replace.
Step 3: Assess Disruption Scenarios
Evaluate scenarios such as:
- Port closure
- Airspace restriction
- Fuel shortage
- Warehouse disruption
- Border closure
- Freight capacity shortage
Step 4: Establish Alternatives
Develop backup options before they are urgently required.
Step 5: Define Inventory Buffers
Set appropriate safety-stock levels based on product and market requirements.
Step 6: Monitor Risk Indicators
Track geopolitical, transportation, fuel, regulatory, and supplier developments.
Step 7: Activate Contingency Plans
Use predefined escalation procedures when disruption thresholds are reached.
Technology in War-Resilient Pharmaceutical Logistics
Digital technology can improve visibility during supply-chain disruption.
Useful capabilities include:
- Real-time shipment tracking
- Inventory dashboards
- Supplier mapping
- Temperature monitoring
- Digital documentation
- Exception alerts
- Demand forecasting
- Route monitoring
Technology does not eliminate physical logistics risks.
Its value is in helping teams identify problems earlier and coordinate responses more effectively.
Supply Chain Diversification and Pharmaceutical Resilience
Recent conflicts have reinforced the importance of diversified health-product supply chains.
WHO has identified sustainable local manufacturing as a strategic priority for building more resilient health systems and reducing vulnerabilities in global health-product supply chains.
For pharmaceutical companies, diversification can involve:
- Multiple suppliers
- Multiple logistics providers
- Alternative routes
- Regional warehouses
- Distributed inventory
- Local or regional manufacturing capabilities
The goal is not to eliminate every risk.
The goal is to avoid excessive dependence on one critical point of failure.
Top Warning Signs Pharmaceutical Companies Should Monitor
Pharmaceutical logistics teams can monitor several indicators.
Shipping Delays
Sudden increases in normal transit times.
Route Changes
Carriers avoiding established transportation corridors.
Freight Price Increases
Rapid increases may indicate capacity or security pressure.
Fuel Shortages
Reduced fuel availability can affect transportation and cold-chain operations.
Port Congestion
Growing vessel or container backlogs.
Airspace Restrictions
Changes affecting cargo flights.
Supplier Delays
Longer lead times for APIs or other inputs.
Warehouse Disruptions
Relocation, restricted access, or infrastructure damage.
Inventory Declines
Falling stock combined with longer replenishment times.
2026–2027 Outlook for Global Pharma Logistics
The pharmaceutical logistics environment in 2026–2027 is likely to remain sensitive to geopolitical developments.
The current Middle East conflict demonstrates how airspace and maritime disruptions can affect medical-supply movement beyond the conflict zone.
Meanwhile, continuing disruptions in other conflict-affected environments show how warehouses, transport infrastructure, and health-supply systems can become operational vulnerabilities.
For pharmaceutical companies, the practical response is not to predict every geopolitical event.
It is to build logistics systems that can adapt when conditions change.
Key priorities include:
- Route diversification
- Supplier diversification
- Inventory planning
- Cold-chain resilience
- Alternative warehousing
- Digital shipment visibility
- Regulatory readiness
- Emergency logistics planning
What Pharmaceutical Exporters Should Prioritize During War
A practical priority framework is:
1. Product Safety
Protect medicine quality and required storage conditions.
2. Supply Continuity
Maintain access to critical products and materials.
3. Route Flexibility
Maintain viable transportation alternatives.
4. Regulatory Compliance
Ensure emergency logistics changes remain compliant.
5. Shipment Visibility
Track products and identify delays early.
6. Communication
Maintain clear communication with customers, distributors, logistics partners, and regulatory stakeholders.
7. Contingency Planning
Prepare alternative routes, suppliers, warehouses, and inventory strategies.
FAQs
What are the biggest pharmaceutical logistics risks during war?
Major risks include transportation disruption, port and airport closures, fuel shortages, warehouse damage, cold-chain failures, border delays, freight-capacity constraints, longer lead times, higher insurance costs, and reduced shipment visibility.
How does war affect pharmaceutical transportation?
War can disrupt roads, ports, airports, shipping routes, and airspace. This can increase transit times, freight costs, insurance costs, and delivery uncertainty.
Can war disrupt medicine exports from India?
Yes. Indian pharmaceutical exports can be affected when international shipping corridors, airspace, ports, freight capacity, fuel markets, or destination-market logistics are disrupted.
Why is cold-chain logistics important during war?
Temperature-sensitive medicines require controlled transportation and storage. Longer routes, power disruptions, delays, or refrigeration failures can increase the risk of temperature excursions.
How can pharmaceutical companies prepare for logistics disruption?
Companies can prepare through alternative routes, multiple logistics providers, appropriate inventory buffers, backup warehouses, shipment tracking, supplier mapping, and documented emergency procedures.
Does logistics disruption always cause medicine shortages?
Not necessarily. The outcome depends on the duration and severity of the disruption, inventory levels, alternative suppliers, transportation options, and the availability of substitute routes or products.
Why Choose Paxter Lifesciences
At Paxter Lifesciences, pharmaceutical export planning considers the complete international supply chain.
Global pharmaceutical logistics can be affected by:
- Geopolitical developments
- Transportation conditions
- Regulatory requirements
- Fuel markets
- Supplier availability
- Destination-market requirements
- International trade conditions
Our approach focuses on structured export coordination and long-term supply continuity.
Insight-Driven Export Planning
International pharmaceutical exports require coordination across multiple stages.
Our approach includes:
- Understanding destination-market requirements
- Supporting regulatory coordination
- Planning international shipments
- Coordinating documentation
- Supporting packaging requirements
- Working around changing logistics conditions
This helps create a more structured export process.
Reliable Pharmaceutical Logistics Coordination
International buyers need dependable communication and shipment planning.
Our service approach emphasizes:
- Clear documentation
- Export coordination
- Shipment planning
- Regulatory alignment
- Market-specific requirements
- Post-shipment communication
These elements support long-term international pharmaceutical partnerships.
Our Pharmaceutical Export Services
Paxter Lifesciences supports pharmaceutical export requirements through:
- Finished dosage form exports
- Pharmaceutical product sourcing
- Regulatory and dossier coordination
- International packaging adaptation
- Export documentation support
- International logistics coordination
- Market-specific supply planning
Finished Dosage Form Export Support
Finished dosage form exports require coordination between manufacturing, quality, documentation, packaging, and transportation.
We support export requirements aligned with international market needs.
Regulatory and Dossier Coordination
International pharmaceutical regulations vary by market.
We support coordination of relevant documentation and regulatory requirements throughout the export process.
International Packaging Adaptation
Packaging requirements can vary between countries.
We support market-specific coordination involving relevant labeling, packaging, and documentation requirements.
Global Logistics Coordination
Reliable logistics are essential to pharmaceutical supply continuity.
Our coordination considers:
- Shipping schedules
- Transportation requirements
- Export documentation
- Destination-market requirements
- Delivery planning
The objective is to support reliable movement of pharmaceutical products across international markets.
Global Pharma Logistics: Building Resilience During War
War demonstrates that pharmaceutical logistics is not simply a transportation function.
It is a critical part of healthcare continuity.
The complete pharmaceutical logistics chain can be represented as:
Raw Materials → API → Manufacturing → Quality Control → Packaging → Warehouse → Transportation → Customs → Distribution → Healthcare Delivery
Disruption at any critical stage can affect the availability and timely delivery of medicines.
For pharmaceutical exporters, resilience therefore requires preparation across the entire chain.
The most important priorities are:
- Diversified logistics routes
- Multiple supply options
- Appropriate inventory planning
- Cold-chain protection
- Alternative warehousing
- Regulatory readiness
- Digital visibility
- Emergency response planning
The central lesson is:
Pharmaceutical logistics during war must prioritize continuity, quality, compliance, flexibility, and patient access—not transportation speed alone.
Schedule Your Pharmaceutical Export Service Today
If geopolitical instability is affecting your pharmaceutical logistics or international sourcing strategy, proactive planning can help improve supply-chain visibility and continuity.
Work with an export partner focused on pharmaceutical quality, regulatory coordination, international logistics, and long-term global partnerships.
Learn more:
Contact us:
Let’s build pharmaceutical export strategies designed for changing global conditions and dependable medicine supply.
Sources & Further Reading
- World Health Organization (WHO) — Middle East Conflict and Health Impact
- World Health Organization (WHO) — Health Impact of the Escalation of Conflict in the Middle East
- World Health Organization (WHO) — Ukraine Humanitarian Warehouse and Medical Supply Disruptions
- World Health Organization (WHO) — Attacks on Health Care and Medical Transport
- World Health Organization (WHO) — Guidance on Health Logistics and Supply-Chain Continuity
- World Health Organization (WHO) — Sustainable Local Manufacturing for Health
- United Nations — Global Health and Humanitarian Logistics Updates